UB Paderborn / Katalog / Suche / in CDI

Critical care medicine, 2010-06, Vol.38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit (6 Suppl), p.S145-S154

2010

Link zum Volltext

Verfügbarkeit prüfen

Management of bleeding and reversal strategies for oral anticoagulants: Clinical practice considerations

American journal of health-system pharmacy, 2013-11, Vol.70 (21), p.1914-1929

2013

Link zum Volltext

Verfügbarkeit prüfen

Racial and gender differences in the incidence of recurrent venous thromboembolism

Thrombosis and haemostasis, 2006-09, Vol.96 (3), p.267

2006

Link zum Volltext

Verfügbarkeit prüfen

Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5628

2022

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline

Chest, 2022-11, Vol.162 (5), p.e207

2022

Link zum Volltext

Verfügbarkeit prüfen

Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors

Seminars in thrombosis and hemostasis, 2017-04, Vol.43 (3), p.270

2017

Link zum Volltext

Verfügbarkeit prüfen

Approaches to Precision-based Anticoagulation management in the critically Ill

Pharmacotherapy, 2023-11, Vol.43 (11), p.1221-1236

2023

Link zum Volltext

Verfügbarkeit prüfen

Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity

Critical care medicine, 2013-05, Vol.41 (5), p.e42-e46

2013

Link zum Volltext

Verfügbarkeit prüfen

Issues in assessing and reducing the risk for venous thromboembolism

American journal of health-system pharmacy, 2010-05, Vol.67 (10 Supplement 6), p.S9-S16

Dager, William E

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of warfarin: Uncovering a piece of the warfarin mystery

American journal of health-system pharmacy, 2009-01, Vol.66 (2), p.123-133

2009

Link zum Volltext

Verfügbarkeit prüfen

Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings

The Annals of pharmacotherapy, 2009-06, Vol.43 (6), p.1064

2009

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

Journal of thrombosis and thrombolysis, 2022-08, Vol.54 (2), p.197-210

2022

Link zum Volltext

Verfügbarkeit prüfen

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients

ASAIO journal (1992), 2021-04, Vol.67 (4), p.411-415

2021

Link zum Volltext

Verfügbarkeit prüfen

Transitioning hospitalized patients from rivaroxaban or apixaban to a continuous unfractionated heparin infusion: A retrospective review

American journal of health-system pharmacy, 2020-08, Vol.77 (Supplement_3), p.S59-S65

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

The Annals of pharmacotherapy, 2022-12, Vol.56 (12), p.1289

2022

Link zum Volltext

Verfügbarkeit prüfen

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

The Annals of pharmacotherapy, 2015-07, Vol.49 (7), p.777

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values

American journal of clinical pathology, 2004-04, Vol.121 (4), p.593-599

2004

Link zum Volltext

Verfügbarkeit prüfen

Implementing anticoagulation management by pharmacists in the inpatient setting

American journal of health-system pharmacy, 2007-05, Vol.64 (10), p.1071-1079

2007

Link zum Volltext

Verfügbarkeit prüfen

Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline

Chest, 2022-11, Vol.162 (5), p.1127

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(97)
Science & Technology
(94)
Life Sciences & Biomedicine
(93)
Pharmacology & Pharmacy
(65)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Female
(33)
Male
(33)
Anticoagulants - Adverse Effects
(31)
Pharmacology. Drug Treatments
(28)
Anticoagulants - Therapeutic Use
(25)
Middle Aged
(23)
Aged
(22)
Adult
(19)
Anticoagulants
(19)
Anticoagulants - Administration & Dosage
(19)
Anticoagulation
(19)
Heparin - Adverse Effects
(16)
Warfarin
(16)
Dose-Response Relationship, Drug
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Removal of Dabigatran by Hemodialysis

Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study

Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis

Developing a management plan for oral anticoagulant reversal

Reversing the anticoagulation effects of dabigatran

Drug-induced thrombocytopenia in critically ill patients

Management of bleeding and reversal strategies for oral anticoagulants: Clinical practice considerations

Racial and gender differences in the incidence of recurrent venous thromboembolism

Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline

Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors

Approaches to Precision-based Anticoagulation management in the critically Ill

Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity

Issues in assessing and reducing the risk for venous thromboembolism

Pharmacogenomics of warfarin: Uncovering a piece of the warfarin mystery

Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients

Transitioning hospitalized patients from rivaroxaban or apixaban to a continuous unfractionated heparin infusion: A retrospective review

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values

Implementing anticoagulation management by pharmacists in the inpatient setting

Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline

Suchergebnisse filtern